GOSS
Pharmaceuticals, Biotechnology & Life Sciences
CROWD: RED
Active holders jumped 76 to 67 recently (-12% in one quarter). Ten years of our own data says fast institutional pile-ins mark late money, not early money. Careful chasing this.
Active holders
67
of 182 total, index funds excluded
This quarter
+29
38 out
Conviction
n/a
Streak
0q
consecutive rising quarters
The crowd, 2016 to now
active holders per quarter
2019Mar 2026
Holdings as of Mar 31, 2026, filed by May 16, 2026. Counts for the newest quarter keep settling for a few weeks as amendments land.
The tide
funds in (up) vs out (down)
Top holders
by reported value · $52.7B held
Fund
Value
Note
BlackRock, Inc.
$5.5B
Kalehua Capital Management …
$3.4B
AQR CAPITAL MANAGEMENT LLC
$3.3B
VANGUARD CAPITAL MANAGEMENT…
$3.1B
ARCH Venture Management, LLC
$2.6B
Octagon Capital Advisors LP
$2.5B
SAMSARA BIOCAPITAL, LLC
$2.4B
Balyasny Asset Management L…
$1.9B
Siren, L.L.C.
$1.7B
683 Capital Management, LLC
$1.6B
Tourists vs true believers
every holder a dot · right = bigger bet in their own book, up = patient money
Hover any dot for the fund and its bet size. Patience is measured from each filer's actual quarter-to-quarter turnover across our whole database.